TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
12,156 |
| Financial expenses |
547
|
2,785
|
11,044 |
| Earnings before taxes |
-11,082
|
-339,194
|
-559,015 |
| EBITDA |
-10,535
|
-338,528
|
-549,072 |
| Total assets |
9,430
|
90,898
|
197,901 |
| Current assets |
6,359
|
47,602
|
142,537 |
| Current liabilities |
8,244
|
71,225
|
170,419 |
| Equity capital |
1,186
|
19,673
|
27,482 |
| - share capital |
243
|
2,696
|
2,703 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
12.6%
|
21.6%
|
13.9% |
| Turnover per employee |
0
|
0
|
6,078 |
| Profit as a percentage of turnover | -4598.7% | ||
| Return on assets (ROA) |
-111.7%
|
-370.1%
|
-276.9% |
| Current ratio |
77.1%
|
66.8%
|
83.6% |
| Return on equity (ROE) |
-934.4%
|
-1724.2%
|
-2034.1% |
| Change turnover |
0
|
-12,156
|
12,156 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.